Tumor Board Review: Guideline And Case Reviews In Oncology by Robert F. Todd IiiTumor Board Review: Guideline And Case Reviews In Oncology by Robert F. Todd Iii

Tumor Board Review: Guideline And Case Reviews In Oncology

byRobert F. Todd IiiEditorKathleen A. Cooney, Teresa G. Hayes

Paperback | February 12, 2015

Pricing and Purchase Info

$123.15 online 
$154.50 list price save 20%
Earn 616 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Praise for the First Edition

As everyone in oncology fellowship training knows, there is a huge information gap in this field. Most oncology books are massive and loaded with information by the time the book is published it is outdated. Tumor Board Review is fresh and just out of the oven. I haven't seen any book in oncology like this so far. I think my investment in this book was wise and worth it.

Humaid Al-Shamsi, MB(Hon), BMedSc, MRCP(UK), FRCP, FACP, Assistant Professor, The University of Texas, MD Anderson Cancer Center

Culling the knowledge and expertise of respected oncology specialists, this is a concise yet comprehensive review of all areas of oncology practice for medical oncologists, radiation oncologists, and pathologists both students and practitioners. The second edition of Tumor Board Review has been thoroughly revised to encompass recent scientific advances in assessment and treatment, new clinical guidelines, and new FDA-approved drugs and indications. It also contains approximately 250 multiple-choice questions and answers to assist readers in testing their knowledge, especially those preparing for the MOC exam.

The book features case presentations and evidence-based management discussions that clearly demonstrate how to apply new information in daily practice. In a consistent format, each chapter addresses epidemiology, risk factors, natural history, and pathology of each major organ-specific tumor type an abbreviated display of relevant staging and several tumor board style illustrative patient case studies. This is followed by an evidence-based case discussion, which reinforces current guidelines and explains the rationale for the diagnostic and therapeutic steps taken. Algorithms and decision-tree graphics further illuminate the decision process.

New To The Second Edition of Tumor Board Review:

  • Presents the most recent guidelines and management standards in user-friendly format
  • Focuses on current indications, use of new drugs, and new treatment of side effects
  • Includes new FDA-approved drugs and guidelines
  • Offers approximately 250 multiple-choice questions and answers
Professor and Chair, Department of Internal Medicine at the University of UtahProfessor of Medicine, and Director of the Hematology/Oncology Fellowship Program at University of Michigan Medical School in Ann Arbor, Michigan
Selves in Time and Place: Identities, Experience, and History in Nepal
Selves in Time and Place: Identities, Experience, and History in Nepal

by Debra Skinner

$36.79$45.95

Available for download

Not available in stores

Tumor Board Review: Guideline and Case Reviews in Oncology
Tumor Board Review: Guideline and Case Reviews in Oncology

by Kathleen A. Cooney, MD

$103.99$129.99

Available for download

Not available in stores

Title:Tumor Board Review: Guideline And Case Reviews In OncologyFormat:PaperbackDimensions:448 pages, 8.75 × 6.35 × 0.68 inPublished:February 12, 2015Publisher:Demos Medical PublishingLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1620700603

ISBN - 13:9781620700600

Look for similar items by category:

Customer Reviews of Tumor Board Review: Guideline And Case Reviews In Oncology

Reviews

Table of Contents

;

Contents

;

Contributors

;

Preface to the Second Edition

;

Preface to the First Edition

;

1.Head and Neck Cancer

;

Assuntina G. Sacco, Irina Y. Dobrosotskaya, and Francis P. Worden

;

2.Thyroid Cancer

;

Alexander T. Pearson, Kevin McDonnell, and Megan Rist Haymart

;

3.Non-Small-Cell Lung Cancer

;

Kunal C. Kadakia and Nithya Ramnath

;

4.Small Cell Lung Cancer

;

Igor I. Rybkin, Binu Malhotra, and Gregory P. Kalemkerian

;

5.Breast Cancer

;

Priya Gomathi Kumaravelu, Aihua Edward Yen, Michelina M. Cairo, Mothaffar F. Rimawi, and Polly A. Niravath

;

6.Esophageal Cancer

;

Ray Esper and Susan G. Urba

;

7.Gastric Cancer

;

Josh Wilfong and Mark M. Zalupski

;

8.Pancreatic Cancer

;

Yue C. Wang, Dongxin Liu, Ahmed A. Eid, and Aihua Edward Yen

;

9.Neuroendocrine Cancer

;

Daniel Da Graca, Mariela Blum, Garrett R. Lynch, and Jun Zhang

;

10.Hepatobiliary Cancers

;

Ghana Kang, Ahmed Awais, Paul Zhang, and Yvonne Sada

;

11.Colorectal Cancer

;

Jasmine Kamboj, Yvonne Sada, and Benjamin L. Musher

;

12.Anal Cancer

;

Ruiling Xu Yuan, Muhammad A. Tarakji, and Elizabeth Yu Chiao

;

13.Prostate Cancer

;

Leonel F. Hernandez-Aya, Jingsong Zhang, Kathleen A. Cooney, and Maha H. Hussain

;

14.Testicular Cancer

;

Diego J. Bedoya, Martha Pritchett Mims, Shamail Butt, and Courtney N. Miller-Chism

;

15.Kidney Cancer

;

Benjamin Y. Scheier, Jenny J. Kim, and Bruce G. Redman

;

16.Bladder Cancer

;

Erin F. Cobain, Colin J. Mooney, and David C. Smith

;

17.Cervical Cancer

;

Andrei Marconescu, Celestine S. Tung, Shan Guo, Concepcion R. Diaz-Arrastia, and Marian Yvette Williams-Brown

;

18.Uterine Cancer

;

Kiran Naqvi, Atisha P. Manhas, and Matthew L. Anderson

;

19.Ovarian Cancer

;

Lan Coffman, Karen McLean, and Ronald J. Buckanovich

;

20.Melanoma

;

Ann W. Silk, Kevin McDonnell, and Christopher D. Lao

;

21.Bone Sarcoma

;

Elizabeth J. Davis and Scott M. Schuetze

;

22.Soft Tissue Sarcoma

;

Dana E. Angelini and Rashmi Chugh

;

23.Primary Brain Tumors

;

Abhishek Marballi, Janet Wang, and Pamela New

;

24.Cancer of Unknown Primary

;

Miho Teruya, Yuval Raizen, and Gerald S. Cyprus

;

25.Hodgkin Lymphoma

;

Jesus H. Hermosillo-Rodriguez, Polly A. Niravath, Catherine M. Bollard, and Carlos A. Ramos

;

26.Non-Hodgkin Lymphoma

;

Premal Lulla and Sarvari Yellapragada

;

27.Multiple Myeloma

;

Vedran Radojcic, Erlene K. Seymour, and Daniel Lebovic

;

28.Acute Lymphoblastic Leukemia

;

Musa Yilmaz and Mark M. Udden

;

29.Acute Myelogenous Leukemia

;

Kavitha Beedupalli and Gustavo Rivero

;

30.Chronic Myeloid Leukemia

;

Alissa A. Weber, Rami N. Khoriaty, and Moshe Talpaz

;

31.Chronic Lymphocytic Leukemia

;

Rami N. Khoriaty and Sami N. Malek

;

32.Myelodysplastic Syndrome

;

Sumana Devata, John Magenau, and Dale Bixby

;

Answers

;

Index

;